Checkpoint Therapeutics Inc. (NASDAQ: CKPT) Stock Information | RedChip

Checkpoint Therapeutics Inc. (NASDAQ: CKPT)


$3.3800
-0.3700 ( -8.40% ) 666.0K

Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in theĀ USA. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR-related protein (GITR) and carbonic anhydrase IX (CAIX). The company is evaluating its lead small-molecule, targeted anti-cancer agent, olafertinib, a third-generation epidermal growth factor receptor ("EGFR") inhibitor, as a potential new treatment for patients with EGFR mutation-positive non-small cell lung cancer.

Market Data


Open


$3.3800

Previous close


$3.7500

Volume


666.0K

Market cap


$167.50M

Day range


$3.3600 - $3.8490

52 week range


$1.3800 - $4.5000

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 56 Nov 12, 2024
8-k 8K-related 15 Nov 12, 2024
4 Insider transactions 1 Oct 01, 2024
8-k 8K-related 15 Aug 12, 2024
10-q Quarterly Reports 56 Aug 12, 2024
8-k 8K-related 15 Jul 25, 2024
8-k 8K-related 23 Jul 03, 2024
4 Insider transactions 1 Jun 28, 2024
4 Insider transactions 1 Jun 28, 2024
8-k 8K-related 15 Jun 24, 2024

Latest News